GLS - Demand emerged at 375-425 in Oct-22After being in downward sloping channel from Aug'21 Plan - Consider to Buy above 425 - and/ or Rejections near 375
Glenmark Life Sciences Ltd. engages in the development and manufacture of non-commoditized active pharmaceutical ingredients. Its products focuses on chronic therapeutic areas, including cardiovascular disease, central nervous system disease, pain management, and diabetes. The company was founded on June 23, 2011 and is headquartered in Mumbai, India.
See all ideas